Avient (AVNT) Q3 2024 earnings summary

Executive summary

• Achieved 8.5% organic sales growth in Q3 2024, with total sales of $815 million, driven by broad-based gains across all regions and most end markets in both CAI and SEM segments.

• Adjusted EPS rose 14% year-over-year to $0.65, exceeding guidance, and adjusted EBITDA increased 6% to $130 million.

• Net income attributable to common shareholders rose to $38.2 million in Q3 2024 from $5.1 million in Q3 2023; GAAP EPS from continuing operations was $0.41, up from $0.06.

• Dividend increased by 5% to $1.08 per share annualized, marking the 14th consecutive year of increases.

• Successfully refinanced $650 million in senior notes, extending maturity to 2031 at 6.25% interest.

Financial highlights

• Q3 2024 sales reached $815.2 million, up 8.2% year-over-year, with adjusted EBITDA of $130 million and adjusted EPS of $0.65.

• Adjusted EBITDA margin was 15.9% in Q3 2024, compared to 16.3% in Q3 2023; adjusted gross margin improved to 32.1% from 25.9% year-over-year.

• Net income from continuing operations for Q3 was $38.2 million, up from $5.1 million year-over-year; operating income for Q3 was $77.2 million, more than double the prior year.

• Cash and cash equivalents at quarter-end were $505.7 million; liquidity of $739.1 million.

• Lower interest expense contributed to EPS growth, following $100 million debt paydown and term loan repricing.

Outlook and guidance

• Full-year 2024 adjusted EPS guidance narrowed to $2.63–$2.67, representing 11–13% growth over the prior year; adjusted EBITDA guidance set at $525–$530 million.

• Q4 adjusted EPS expected in the range of $0.46–$0.50, including a $15 million headwind from variable compensation accruals.

• Management expects sufficient liquidity for the next twelve months and foreseeable future, with cash needs covered by operations and available credit.

• Continued strong demand trends in the U.S., Canada, Asia, and Latin America; muted growth expected in EMEA due to automotive and defense market headwinds.